Amgen EVP covers taxes with 615-share stock disposition

Amgen Inc. executive vice president of Global Commercial Operations Murdo Gordon reported a small stock transaction related to taxes.

Rhea-AI Filing Summary

Amgen Inc. executive vice president of Global Commercial Operations Murdo Gordon reported a small stock transaction related to taxes. On a Form 4, he showed a tax-withholding disposition of 615 shares of Amgen common stock at $331.11 per share, a mechanistic step to cover obligations associated with equity compensation rather than an open-market sale. After this transaction, he directly holds 51,222 shares of Amgen common stock. The reported holdings include 386 Dividend Equivalents tied to unvested restricted stock units under Amgen’s equity incentive plan, which will be paid out in shares as those units vest.

Insider Trade Summary

Exercise Price or Tax Liability: 615 shares

Exercise Price or Tax Liability 1 txn

Insider Gordon Murdo

Role EVP, Global Commercial Ops

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	615	$331.11	$204K

Holdings After Transaction: Common Stock — 51,222 shares (Direct)

Footnotes (1)

1. F1. These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Tax-withholding shares: 615 shares Tax-withholding price: $331.11 per share Shares held after transaction: 51,222 shares +1 more

4 metrics

Tax-withholding shares 615 shares Common stock disposed on Form 4 as tax-withholding

Tax-withholding price $331.11 per share Price per Amgen share for 615-share disposition

Shares held after transaction 51,222 shares Direct Amgen common stock holdings following Form 4 event

Dividend Equivalents included 386 DEs Dividend Equivalents tied to unvested RSUs in holdings

Key Terms

Dividend Equivalents (DEs), Restricted Stock Units, Equity Incentive Plan, tax-withholding disposition

4 terms

Dividend Equivalents (DEs) financial

"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" and transaction_code_description: "Payment of exercise price or tax liability by delivering securities""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amgen (AMGN) report for Murdo Gordon?

Amgen reported that EVP Global Commercial Operations Murdo Gordon disposed of 615 shares of common stock. The Form 4 states this was a tax-withholding disposition, meaning shares were withheld to satisfy tax obligations tied to equity compensation, not an open-market sale.

How many Amgen (AMGN) shares did Murdo Gordon dispose of for taxes and at what price?

Murdo Gordon had 615 Amgen common shares withheld for taxes at $331.11 per share. The filing describes this as a tax-withholding disposition to cover exercise price or tax liability, rather than a discretionary buy or sell transaction in the open market.

How many Amgen (AMGN) shares does Murdo Gordon hold after this Form 4 transaction?

After the reported tax-withholding event, Murdo Gordon directly holds 51,222 shares of Amgen common stock. This total includes shares associated with his equity awards and reflects his position following the 615-share disposition recorded in the Form 4 filing.

What does the Form 4 say about Dividend Equivalents in Murdo Gordon’s Amgen (AMGN) holdings?

The Form 4 notes that Gordon’s holdings include 386 Dividend Equivalents granted under Amgen’s 2009 Equity Incentive Plan. These Dividend Equivalents are credited to unvested restricted stock units and will be paid out in Amgen common shares as the units vest, plus cash for any fractional share.

Is Murdo Gordon’s Amgen (AMGN) Form 4 transaction a routine tax-withholding event?

Yes. The transaction is coded “F” and described as payment of exercise price or tax liability by delivering securities. This indicates a routine tax-withholding disposition associated with equity compensation, rather than an elective open-market purchase or sale of Amgen shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 07:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Murdo

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Commercial Ops

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		615	D	$331.11	51,222(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Murdo Gordon	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)